Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Folic acid is highly effective for prevention of neural tube defects (NTDs) when administered in the first trimester of pregnancy and the benefits are linearly related to plasma folate levels. Folic acid also lowers plasma homocysteine that has been linked with risk of stroke. However, the effects of different folic acid fortification types on NTD prevalence and stroke are uncertain. This presentation will review current folic acid fortification policies and their relevance for NTD and stroke prevention.

Robert Clarke is a Professor of Epidemiology and Public Health Medicine, Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford. 

 

This talk is open to members of the University only.

Forthcoming events

Opium as a carcinogen: new insights from the Golestan Cohort Study

Tuesday, 28 May 2024, 1pm to 2pm @ Richard Doll Lecture Theatre, Richard Doll Building, Old Road Campus, Headington, OX3 7LF

Exploiting electronic health records to improve infection management

Monday, 03 June 2024, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

Title TBC

Tuesday, 04 June 2024, 1pm to 2pm @ Richard Doll Lecture Theatre, Richard Doll Building, Old Road Campus, Headington, OX3 7LF

Prevention of Chronic Kidney Disease Progression

Tuesday, 11 June 2024, 1pm to 2pm @ Richard Doll Lecture Theatre, Richard Doll Building, Old Road Campus, Headington, OX3 7LF

Festival of Global Health - Survivors

Wednesday, 12 June 2024, 4pm to 8pm @ Curzon Oxford, Westgate Shopping Centre, Oxford OX1 1NZ